Product NDC: | 49288-0678 |
Proprietary Name: | Treatment Set TS129259 |
Non Proprietary Name: | Treatment Set TS129259 |
Active Ingredient(s): | 400; 2000 [AU]/mL; [AU]/mL & nbsp; Treatment Set TS129259 |
Administration Route(s): | INTRADERMAL; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49288-0678 |
Labeler Name: | Antigen Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA102223 |
Marketing Category: | BLA |
Start Marketing Date: | 19861031 |
Package NDC: | 49288-0678-3 |
Package Description: | 10 mL in 1 VIAL, MULTI-DOSE (49288-0678-3) |
NDC Code | 49288-0678-3 |
Proprietary Name | Treatment Set TS129259 |
Package Description | 10 mL in 1 VIAL, MULTI-DOSE (49288-0678-3) |
Product NDC | 49288-0678 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Treatment Set TS129259 |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRADERMAL; SUBCUTANEOUS |
Start Marketing Date | 19861031 |
Marketing Category Name | BLA |
Labeler Name | Antigen Laboratories, Inc. |
Substance Name | DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS |
Strength Number | 400; 2000 |
Strength Unit | [AU]/mL; [AU]/mL |
Pharmaceutical Classes | Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] |